Clinical & Experimental Cardiology (ISSN: 2155-9880)

Description

About the Journal
NLM ID:101574126
Index Copernicus Value: 106.75
Lifestyle diseases have been a cause of concern in the recent times. Cardiovascular Disease (CVD) remains at the top in this hierarchy. CVD deals with the heart and allied vascular conditions at large. The Journal of Clinical & Experimental Cardiology is a scholarly Open Access journal which provides comprehensive coverage of modern practices in cardiovascular therapy. This journal aims to disseminate information on current problems in the clinical cardiology along with facts on technological advancements that took place in treating the cases. Articles are welcome in the form of research articles, review articles, case reports, short communications and commentaries on relevant topics. The editorial office ensures a rigorous peer review process for the submitted manuscripts for maintaining the quality of publishing and in achieving high journal impact factor.
The Journal of Clinical & Experimental Cardiology is a scholarly open access journal which considers topics on apical hypertrophic cardiomyopathy, coronary artery ectasia, fetal heart calcification, chronic arterial insufficiency, cardiovascular disease and its association with cancer, peri-arrest period, complications after heart surgery, early repolarization symptoms, coronary arteritis, inflammatory vascular disease, inflammatory cardiomyopathy, systolic pressure variation, left atrium enlargement, ventricular septal defect (VSD), association of abiotrophia species with heart problem, various heart and blood vessel disorders, myocardial infarction (heart attack), relevant issues of cardiac arrest, stroke, techniques and procedure used in stent implantation, anticoagulant drugs (blood thinners), basic research in heart structure and functions and other medical conditions and associated treatments etc. Information on latest therapeutic efforts such as application of cardiac progenitor cells, angioplasty, percutaneous coronary intervention (PCI) such as percutaneous transluminal coronary angioplasty (PTCA), and other stent implantation, anticoagulant drugs (blood thinners), therapy after open heart surgery, use of ventricular assist device.